Literature DB >> 20818912

Hemolytic anemia after eculizumab in paroxysmal nocturnal hemoglobinuria.

Alessandra Berzuini, Fabio Montanelli, Daniele Prati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818912     DOI: 10.1056/NEJMc1005108

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test.

Authors:  B Höchsmann; R Leichtle; I von Zabern; S Kaiser; W A Flegel; H Schrezenmeier
Journal:  Vox Sang       Date:  2011-09-19       Impact factor: 2.144

Review 2.  Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles J Parker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Antibody Inhibition of Properdin Prevents Complement-Mediated Intravascular and Extravascular Hemolysis.

Authors:  Damodar Gullipalli; Fengkui Zhang; Sayaka Sato; Yoshiyasu Ueda; Yuko Kimura; Madhu Golla; Takashi Miwa; Jianxiang Wang; Wen-Chao Song
Journal:  J Immunol       Date:  2018-06-13       Impact factor: 5.422

Review 4.  Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective.

Authors:  Bruno Fattizzo; Francesca Cavallaro; Esther Natalie Oliva; Wilma Barcellini
Journal:  J Blood Med       Date:  2022-06-17

5.  Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab.

Authors:  Ji Young Moon; Deog-Yeon Jo; So Yeon Lee; Deok Yeong Kim; Seung-Woo Baek; Ik-Chan Song
Journal:  Blood Res       Date:  2017-12-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.